RARRES2 and Cognitive impairment: Given that chemerin treatment and activation of NLRP3 triggers the inflammatory response and pyroptosis, leading to neurological damage [29, 30], we speculate that removing ChemR23 and CCRL2 may relieve chemerin-mediated neuron loss and cognitive impairment by inhibiting the formation of the NLRP3 inflammasome.